COVID-19 vaccine maker BioNTech said on Tuesday that it and partner Pfizer have filed a complaint with the U.S. District ...

The civil suit claims that once CureVac had withdrawn its vaccine candidate, the company was unable to garner 50% efficacy in ...

COVID-19 vaccine maker Biontech said on Tuesday that it and partner Pfizer have filed a complaint with the U.S. District ...

BioNTech, with its partner Pfizer, expects to begin deliveries of two omicron-adapted vaccines as soon as October in time for ...

The lawsuit, filed Monday, said CureVac is trying to profit from the success of BioNTech and Pfizer's COVID-19 vaccines after ...